FDA Inspection
Merakris Therapeutics, LLCMerakris Therapeutics, LLC – FDA Inspection, Jun 30, 2022
Record Details
This FDA Inspection record concerns Merakris Therapeutics, LLC, with an inspection on June 30, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Merakris Therapeutics, LLC
- Inspection Date
- June 30, 2022
- Product Type
- Biologics
View Company Profile
ID · f3b9ab0d-4f34-445d-863c-7f93f2a946fe
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1177756
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Merakris Therapeutics, LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| May 15, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Merakris Therapeutics, LLC
- FDA Inspection 1238909 - 2024-05-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.